Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 42.5 | 36 | |
N2586 | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 35.5 | 32 | ||||
N2586 | EO1428 | 1.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 36.0 | 32 | |
N2586 | PI103 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 31.0 | 25 | |
N2586 | Sigma A6730 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 40.0 | 33 | |
N2586 | JNK-IN-8 | 3.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 25.0 | 27 | |
N2586 | JNK-IN-11 | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 46.5 | 42 | |
0 | IL-13 | 14.0 | 66 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 51.0 | 66 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 53.5 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 41.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 46.5 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 50.0 | 57 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 44.0 | 65 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 54.0 | 54 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 50.0 | 65 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 45.0 | 63 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 49.5 | 58 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 54.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | IL-13 | 71.0 | 71 | |
RA2159 | 3 | IL-13 | 39.0 | 63 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-13 | 49.0 | 51 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-13 | 43.0 | 41 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-13 | 42.0 | 53 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-13 | 40.0 | 80 |